The global varicose vein treatment market is set to witness a growth rate of 6% in the next 5 years. High prevalence of ...

The global Gastrointestinal Devices market is expected to witness a CAGR of ~5% during the forecast period, is driven by aging populations, rising GI procedures, and colorectal cancer cases. GI ...

The global biosimilars market growth is driven by increasing number of biosimilar approvals and rising number of biologics going off-patent.A biosimilar is a biological product that is similar to a ...

The in vitro toxicity testing market is projected to grow at a CAGR of ~10% over the forecast period. Major factors driving ...

The global knee reconstruction devices market is projected to grow at a CAGR of 5.5% from 2025 to 2030, fueled by the ...

Ovation Data, a leader in data management and digital transformation, warns that neglecting data risks losing valuable insights forever and offers practical advice to address this in its ...

MURFREESBORO, TN / ACCESS Newswire / June 2, 2025 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor presentation which can be found at: presentation updates NHI's ...

Change in Forecast/DividendGerresheimer AG: Adjustment of Guidance for 202502-Jun-2025 / 11:40 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, ...

The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030. Key drivers include ...

The echocardiography (ECG) market is projected to grow at a CAGR of ~7% over the forecast period. Major factors driving ...

Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 DevelopmentMelbourne, Australia and Oxford, UK– 2 June 2025, Aravax, a clinical-stage biotechnology ...

Introduction: The global botulinum toxin market has evolved from being a beauty-industry phenomenon to becoming a ...